With US futures trading higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Occidental Petroleum Corporation (NYSE: OXY) to post
Millennial investors might think investing is easy and "stocks only go up." But a few of their popular holdings are sinking fast.
Here are some of the most active stocks in the premarket on Monday. U.S. stock futures ES00, +0.50% were pointing to an advance after the worst week for the S&P 500 SPX, -1.05% since the period that e
The deal would strengthen Pfizer's lineup of cancer treatments, The Wall Street Journal reports.
Pfizer Inc. is in talks to acquire biotech Seagen Inc., according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targete

Pfizer In Early Talks To Buy Cancer-Focused Seagen: WSJ

03:14am, Monday, 27'th Feb 2023 Benzinga
Pfizer Inc (NYSE: PFE) is in early discussions to purchase biotechnology company Seagen Inc (NASDAQ: SGEN), The Wall Street Journal reported late on Sunday, citing people familiar with the matter.
Pfizer Inc is in early talks to acquire drugmaker Seagen Inc , the Wall Street Journal reported late on Sunday, citing people familiar with the matter.

Pfizer in Early-Stage Talks to Acquire Seagen

09:56pm, Sunday, 26'th Feb 2023
Pfizer Inc. is in talks to acquire biotech Seagen Inc, according to people familiar with the matter, the latest potential deal for a big drug company aimed at adding a promising class of targeted canc
Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see the companies with upcoming ex-dividend dates.
Ukraine’s GDP fell by 30.4% in 2022, according to the country’s Ministry of Economy.
FDA approves Sanofi's (SNY) Altuviiio and grants a priority tag to Pfizer's (PFE) regulatory applications for pipeline candidates.
The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
Pfizer Inc. (NYSE: PFE) may have ten blockbuster drugs in its pipeline, but it seems much of the company's near-term potential could be based on the success of two important Phase 3 studies.  Analyst
The company is doubling down on its vaccine success.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a hig
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE